CoChat

Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C

Fujita, Naoki, Sugimoto, Ryosuke, Urawa, Naohito, Araki, Jun, Mifuji, Rumi, Yamamoto, Mika, Horiike, Shinichiro, Tanaka, Hideaki, Iwasa, Motoh, Kobayashi, Yoshinao, Adachi, Yukihiko, Kaito, Masahiko · 2007 · Journal of Gastroenterology and Hepatology
Cited by 109

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background and Aims: Liver iron accumulation in patients with chronic hepatitis C (CHC) has received increasing attention in recent years. The aim of this study was to determine the prevalence and severity of liver iron deposition in CHC, to assess its relationship with clinical, biochemical and histological characteristics, and to study its influence on the response to interferon (IFN) plus ribavirin combination therapy. Methods: We studied liver biopsy specimens from 103 hepatitis C virus (HCV) and 34 hepatitis B virus (HBV) infected patients and total iron score (TIS) was measured. Seventy patients infected with HCV genotype 1b were treated with IFN/ribavirin for 24 weeks. Results: CHC patients had a significantly higher TIS than chronic hepatitis B (CHB) patients (7.03 ± 5.34 vs 4.41 ± 4.49,P = 0.0056). TIS was significantly correlated with alcohol intake (P = 0.0213,r = 0.290), transaminase level (P = 0.0126,r = 0.247), platelet count (P = 0.0002,r = −0.369), histological grading (P = 0.0121,r = 0.248) and staging (P = 0.0003,r = 0.356) in CHC patients. Pretreatment TIS was significantly higher in non‐sustained virological responders (SVR) than in SVR to IFN/ribavirin treatment (TIS = 7.69 ± 5.76 vs 4.39 ± 3.27,P = 0.0310). Multiple regression analysis showed that TIS was the only independent variable associated with resistance to IFN/ribavirin (P = 0.0277). Conclusions: Liver iron deposition was common in CHC compared to CHB and was associated with liver disease progression. Increased hepatic iron stores in CHC were related to resistance to IFN/ribavirin treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1746.2006.04759.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 109

Metadata

Authors
Fujita, N., Sugimoto, R., Urawa, N., Araki, J., Mifuji, R., Yamamoto, M., Horiike, S., Tanaka, H., Iwasa, M., Kobayashi, Y., Adachi, Y., & Kaito, M.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2007-10-02
Volume
22
Issue
11
Pages
1886-1893
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W2007731629
Cited by
109
References
2
FWCI
5.06
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. https://app.cochat.ai/papers/10.1111/j.1440-1746.2006.04759.x
The paper
Fujita, N., Sugimoto, R., Urawa, N., Araki, J., Mifuji, R., Yamamoto, M., Horiike, S., Tanaka, H., Iwasa, M., Kobayashi, Y., Adachi, Y., & Kaito, M. (2007). Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2006.04759.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.